Aminoglycosides and polymyxin B as inhibitors of antigen attachment to erythrocytes for agglutination by Salmonella antibodies.
Previous investigations indicate that polymyxin B inhibits attachment of lipopolysaccharides (O antigens) to erythrocytes and subsequent hemagglutination by the corresponding bacterial antibodies. In this study the effect of this antibiotic was compared to that of  the aminoglycosides gentamicin, tobramycin, and amikacin. Using both crude O antigens and highly purified lipopolysaccharides, polymyxin B was at least 100 times more effective than the aminoglycosides. Amikacin proved to be less effective than gentamicin and tobramycin.
D000617:Aminoglycosides / Q000494:pharmacology*; D000907:Antibodies, Bacterial / Q000276:immunology; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D000942:Antigens, Bacterial / Q000276:immunology; D004912:Erythrocytes / Q000187:drug effects*; D006384:Hemagglutination / Q000187:drug effects*; D008070:Lipopolysaccharides / Q000276:immunology; D011112:Polymyxin B / Q000494:pharmacology*; D011113:Polymyxins / Q000494:pharmacology*; D012475:Salmonella / Q000276:immunology
D000617:Aminoglycosides; D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D008070:Lipopolysaccharides; D011113:Polymyxins; D011112:Polymyxin B